Lin Y.-L.KUN-HUEI YEHANN-LII CHENG2021-01-282021-01-2820110929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955503234&doi=10.1016%2fS0929-6646%2811%2960001-6&partnerID=40&md5=7168e1bfb65042e5a9b16145fbcb0aa0https://scholars.lib.ntu.edu.tw/handle/123456789/543515[SDGs]SDG3bevacizumab; cetuximab; fluorouracil; folinic acid; irinotecan; oxaliplatin; colorectal cancer; diarrhea; human; low drug dose; metastasis; note; peripheral neuropathy; personalized medicine; stomatitis; Taiwan; vomitingRecent advances in the treatment of metastatic colorectal cancer in Taiwannote10.1016/S0929-6646(11)60001-62-s2.0-79955503234